Skip to main content
. 2019 Aug 13;9:764. doi: 10.3389/fonc.2019.00764

Table 2.

Comparison of BCR-ABL1 DTs in patients with transcript increases but different clinical outcomes.

Clinical context of BCR-ABL1 rise No of patients DT (range) Median BCR-ABL1/ABL1IS before rise (range) Median BCR-ABL1/ABL1IS after rise (range) p-value
BCR-ABL1 increase with IM failure 118 41.45 (8.4–281.9) 0.076 (0.002–0.0943) 0.460 (0.110–48.93) p = 0.0114
BCR-ABL1 increase w/o MR3.0 loss 187 57.80 (14.3–356.2) 0.006 (0.00–0.031) 0.018 (0.002–0.100)